Skip to main content

ESSA Pharma Inc.

EPIXDelisted Oct 9, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001633932

ESSA Pharma Inc. was delisted on Oct 9, 2025; its insiders filed their last Form 4 on Oct 15, 2025; 32 institutions reported holding it in 13F filings for Q3 2025, worth $4.30M in total; no superinvestor held it.

Q2 2022 vs. Q1 2022

How the institutions holding ESSA Pharma Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of EPIX: Q1 2022 compared with Q2 2022
MeasureQ1 2022Q2 2022Change
Holders7059−11
Shares37.2M37.8M+576.7K (+1.6%)
Value$229.9M$119.0M−$110.9M (−48.2%)

New holders (8)

Institutions that held ESSA Pharma Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to EPIX in Q2 2022
InstitutionSharesValue% of portfolio
PFM Health Sciences, LP961,716$3.03M0.12%
HRT Financial LP53,443$168.0K0.00%
Alps Advisors Inc26,140$82.0K0.00%
Renaissance Technologies LLC25,600$81.0K0.00%
Marshall Wace, LLP21,393$67.0K0.00%
Crewe Advisors LLC265$1.00K0.00%
Federation des caisses Desjardins du Quebec50$1580.00%
Rockefeller Capital Management L.P.132$00.00%

Sold out (19)

Institutions that held ESSA Pharma Inc. at the end of Q1 2022 and filed for Q2 2022 without it.